| ROCKET PHARMACEUTICALS |
| USA |
| Gesundheit |
| US77313F1066 / A2JA9Q |
| 9IP1 (Frankfurt) / RCKT (NASDAQ) |
| FRA:9IP1, ETR:9IP1, 9IP1:GR, NASDAQ:RCKT |
| - |
| https://www.rocketpharma... |
|
Rocket Pharmaceuticals Inc. is a late-stage biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company employs a multi-platform approach utiliz..
>Volltext.. |
| 440.47 Mio. EUR |
| 300.5 Mio. EUR |
| - |
| -188.57 Mio. EUR |
| -193.42 Mio. EUR |
| -1.74 EUR |
| 21.57 Mio. EUR |
| 67.23 Mio. EUR |
| -164.75 Mio. EUR |
| 6.25 |
| - |
| 23.99% |
| - |
| - |
| - |
| - |
| ROCKET PHARMACEUTICALS, ROCKET PHARMA, ROCKET PHARMACEUTICAL |
| 27.03.26 |